MS-SMART trial continues – but what is it?

Hi everyone,

Just thought I would update you on the MS-SMART trials, as we have been chatting about it here in the office…

Photo of Ryan for blog

Ryan Jones, MS-UK

Even if the MS-SMART trial is not suitable for you, or not something you would consider taking part in, as there are currently no medications available for people with secondary progressive multiple sclerosis (SPMS) it is worth knowing this is happening.

MS-SMART is a phase 2 clinical trial looking at disease progression in people with secondary progressive MS (SPMS). The fact that this trial started straight to ‘Phase 2’ means that the safety and tolerability of the drugs being tested is already known.

The study involves testing three medications that are already available and licenced for use in other conditions. This trial is seen as innovative as it is studying more than one drug at the same time, which could greatly speed up the process of making them available should the overall trial be successful.

It is thought that the medications being studied have neuroprotective qualities and the aim of the trial is to see if they can save nerves from being damaged further and slow down the progression of disability.

The medications being trialled are:

  • Amiloride – used for treating a heart disease
  • Riluzole – used for people with Motor Neurone Disease
  • Fluoxetine – used for treating depression and more commonly known as Prozac

The trial is running at various sites around the UK including London, Liverpool, Brighton, Edinburgh, Newcastle, Nottingham, Oxford, Plymouth, Sheffield, Stoke-on-Trent and Truro. The trial is open and in total needs to recruit 440 participants. It is recruiting up until the end of April 2016.

The lead researcher is Jeremy Chataway based at University College London. The trial has an inclusion criteria which anyone wishing to take part must meet. For more information including how to contact the researchers and for the inclusion criteria please see https://clinicaltrials.gov/ct2/show/NCT01910259. The MS-SMART website may also be of interest at http://www.ms-smart.org/.

We will share updates and the results of the trial when they become available, but in the meantime if you have any questions, don’t hesitate to contact me on the MS-UK Helpline – you can call 0800 783 0518 or connect via our live web chat service.

Best wishes,

Ryan

Ryan Jones, MS-UK Helpline

Advertisements
This entry was posted in MS, MS News, MS-UK, Multiple Sclerosis, Research, Uncategorized and tagged , , , , , , , , . Bookmark the permalink.

2 Responses to MS-SMART trial continues – but what is it?

  1. I’m not in the UK 😦 but very excited to hear this! I was just diagnosed and didn’t realize there were stages of MS until after I left the docs (u think he would have mentioned which one he thinks I’m in) but after a great deal of research I feel I’m in secondary progression :/ I see him this month and will talk more but please keep us posted on this research!

    Liked by 1 person

  2. msuk2015 says:

    Hi – we have a news section on our website which has all the latest MS research and breaking news added on a daily basis – just visit http://www.ms-uk.org/MSnews to keep up to date!
    Cheers 🙂

    Liked by 1 person

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s